BioSpace News Archive

Deals

Leidos to Acquire IMX Medical Management Services

Acquisition extends QTC’s independent medical evaluation coverage area for commercial and federal customers

August 7, 2019
·
2 min read
Business

Planmeca USA Moves U.S. Headquarters to Larger, More Technologically-Advanced Facility

New Office to House High-Tech Showroom and Planmeca Digital Academy, Offering Hands-on Training and Education Solutions

August 7, 2019
·
2 min read
Business

TURALIO™ (pexidartinib), FDA Approved Treatment of TGCT, Available at Biologics by McKesson

Exclusive distribution agreement with Daiichi Sankyo, Inc. expands rare disease and complex therapeutic specialty pharmacy needs

August 7, 2019
·
3 min read
Deals

Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent® For Therapeutic Platform

Vesselon will use Imagent to create novel therapeutic complexes in four classes of cancer drugs: cytokines, oncolytic viruses, monoclonal antibodies, and nucleic acid constructs.

August 7, 2019
·
4 min read
Biotech Beach

NuSight Medical Sells 5,000 NuLids Systems

NuLids System will significantly improve both the signs and symptoms associated with most dry eye disease in less than 30 days.

August 7, 2019
·
3 min read
Business

Biodesix Adds Dr. Charles Watts to Board of Directors

Distinguished Pulmonology-Critical Care Specialist Joins Lung Cancer Diagnostic Solutions Company

August 7, 2019
·
2 min read
Business

VIVA and Wiley Drive Open Access with Progressive New Agreement

The two-year pilot utilizes the Wiley Open Access Account solution to allow VIVA researchers to publish in fully gold open access journals using a central fund for article publication charges

August 7, 2019
·
3 min read
BioCapital

Study Shows Certified Pharmacy Technicians are More Committed to a Pharmacy Career Than Noncertified

More likely to seek expanded responsibilities

August 7, 2019
·
3 min read
Biotech Bay

Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering

The combined purchase price for one share of common stock and each warrant will be $0.75.

August 7, 2019
·
4 min read
Drug Development

Numerate Receives $2 Million SBIR Phase II Award to Continue Research Using Its AI-Driven Discovery Platform to Identify New Antiarrhythmic Drug

Numerate and the UCLA Cardiovascular Research Laboratory to advance collaboration to identify superior therapy for treatment and prevention of ventricular tachycardias and fibrillation

August 7, 2019
·
5 min read